TrialBreast cancer research and treatment2014

Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine.

George Dranitsaris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.